Clinical observations in ERα deficient male or with decreased levels of aromatase noted the development of increased body weight, insulin resistance, and hyperinsulinemia (Smith et al., 1994; Jones et al., 2007). The gene discussed is CYP19A1; the disease is Insulin resistance.